Drug Shortage Report for TARO-ZOLEDRONIC ACID

Last updated on 2025-01-21 History
Report ID 166405
Drug Identification Number 02415100
Brand name TARO-ZOLEDRONIC ACID
Common or Proper name ZOLEDRONIC
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-08-09
Actual start date
Estimated end date
Actual end date 2024-07-01
Shortage status Resolved
Updated date 2025-01-21
Company comments Recall with no back up inventory currently available
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v45 2025-01-21 French Compare
v44 2025-01-21 English Compare
v43 2025-01-07 French Compare
v42 2025-01-07 English Compare
v41 2024-11-11 French Compare
v40 2024-11-11 English Compare
v39 2024-09-09 French Compare
v38 2024-09-09 English Compare
v37 2024-06-14 French Compare
v36 2024-06-14 English Compare
v35 2024-05-07 French Compare
v34 2024-05-07 English Compare
v33 2024-01-05 French Compare
v32 2024-01-05 English Compare
v31 2023-08-16 French Compare
v30 2023-08-16 English Compare
v29 2023-07-18 French Compare
v28 2023-07-18 English Compare
v27 2023-04-10 French Compare
v26 2023-04-10 English Compare

Showing 1 to 20 of 45